Regenerative Chlorine Dioxide Explained
The release behaviour claimed for ChloroKlean Plus L20, how residual persistence should be measured, and which statements require product-specific verification.
Regenerative chlorine dioxide is the supplier term used for ChloroKlean Plus L20's claimed release behaviour. This page explains what that description does and does not establish. Residual persistence, dose, efficacy, biofilm outcomes and comparisons with other systems require product-specific evidence and verification in the intended use.
What 'Regenerative' Means in This Context
Chlorine dioxide may be generated on site or supplied through a packaged product, with different preparation and dosing arrangements. In every case the active is consumed by system demand; its concentration-time profile must be measured rather than inferred from the format.
Plus L20 is described by its supplier as holding chlorine dioxide in a stabilised liquid matrix and releasing measurable active after dilution. The magnitude and duration of that release must be established under the actual water chemistry, demand and operating conditions.
The formulation description does not prove a longer residual than every alternative, a smaller required mass, or a sustained microbiological kill. Those are separate product and site outcomes.
How to Verify Residual Persistence
A residual can deplete between applications, and regrowth can occur where the wider control programme is inadequate. A residual trend alone does not diagnose the reason for a microbiological failure or establish the response.
Measure the residual profile at representative points and times; do not infer reduced treatment gaps or prevention of recolonisation from a formulation description. Any EN result must identify the product, organism, matrix, concentration, contact time and test conditions. Field programmes require routine sampling and operational verification rather than conversion of a laboratory result into a generic dose.
Published chlorine dioxide biofilm studies report condition-specific effects. They do not establish that Plus L20 reaches the bottom of every biofilm, kills all embedded cells or outperforms a periodic programme. Cleaning and site verification remain necessary.
How Regenerative ClO2 Compares to Other Chemistries
Sodium hypochlorite has pH-dependent active-species chemistry and can form chloramines, THMs and HAAs under relevant conditions. That does not establish a blanket efficacy or biofilm ranking.
Tablet, two-part and generator systems have different release profiles, controls and handling requirements. Compare current technical evidence, residual measurements and risk assessments rather than assuming faster decay or greater operator risk.
On-site generators have installation, maintenance and operating requirements that should be compared with packaged products using documented whole-life cost and risk data.
ChloroKlean Plus L20 is a single-pack product whose claimed residual persistence must be verified under the intended conditions. It is supplied for stated Great Britain PT2, PT4, PT5 and PT11 uses under applicable transitional arrangements; each intended use, precursor route, product type and label must be checked.
Concentration Is Not Coverage: Formulation, Wetting and Surface Contact
The regenerative discussion above is about how much active is present in the water and for how long. On a surface a second variable enters that is easy to overlook: how much of the surface the solution actually touches for the contact time. A disinfectant only acts where liquid and surface are in contact. Water has a high surface tension, so on hydrophobic or textured surfaces (many plastics, greasy stainless steel, worn elastomers, the underside of fittings) a sprayed or wiped solution beads, drains and dries unevenly, leaving areas that saw a fraction of the nominal contact time or none at all. Two solutions at identical chlorine dioxide concentration can therefore give different results on the same surface if one spreads and the other does not.
Formulation science addresses this with wetting agents (surfactants) and with the physical action of the application method. A study published in GMS Hygiene and Infection Control on 12 August 2024 (Tarka et al.; doi 10.3205/dgkh000492) illustrates the point for chlorine dioxide. The authors tested three chlorine dioxide surface disinfectants formulated with acetic or citric acid and a surfactant, against poliovirus, adenovirus and murine norovirus under interfering-substance (dirty) conditions, using the EN 14476 suspension test, the EN 16777 carrier test without mechanical action and the EN 16615 four-field test that simulates wiping. The formulations were virucidal within 5 minutes. Two observations are the useful ones here: reductions against murine norovirus and adenovirus were lower in the carrier test than in suspension for the concentrate and gel formulations (the foam did not show the same drop), because a dried film on a surface is a harder target than organisms bathed in liquid, and the highest chlorine dioxide concentration tested in suspension (100 ppm) gave lower reductions than 25 and 50 ppm against some viruses, which the authors attribute to viral aggregation at the lower pH of the stronger working solution. More active is not automatically more effective; how the solution meets the target matters. Two of the five authors were employed by the company that developed the formulations, and the work was publicly co-funded under a Polish development programme.
Read carefully, the study does not show that adding a surfactant to any chlorine dioxide solution improves it, and it says nothing about ChloroKlean products, which were not tested. Its lesson is a general one: an efficacy result belongs to the formulation and the application method that produced it, not to the active concentration alone. For water-system dosing this argues for verifying that the treated water actually reaches every part of the system (dead legs, low-flow branches, the wetted surfaces of tanks above the water line). For surface use it argues for following the label's application method, keeping the surface visibly wet for the full contact time, and pre-cleaning so that soil does not stand between the solution and the surface. Where a ChloroKlean product is used for surface disinfection, the applicable contact time and method are those on its label for the product type, not figures from third-party studies of other formulations.
What Regenerative Behaviour Does Not Mean
Regenerative does not mean infinite. The active eventually depletes and the product must be used in line with its current conditions and the site plan. Any claim of a longer redose interval or flatter residual curve requires measurement against a defined comparator.
It does not bypass the requirement for a written scheme of treatment under ACOP L8 for systems within scope, COSHH assessments, or routine monitoring of chlorine dioxide residual, microbiology and chemical parameters. It should not be claimed to make those programmes easier without evidence.
Finally, it does not mean the product is harmless at concentrate strength. ChloroKlean Plus L20 in its packed form is a hazardous oxidiser and must be handled with PPE as set out in the Safety Data Sheet.
GB BPR status and verification
ChloroKlean products are supplied for their stated Great Britain uses under applicable GB BPR transitional arrangements while the relevant chlorine dioxide precursor-route and product-type combinations remain in the GB Review Programme. This is not a claim of full product authorisation. No EU or Northern Ireland authorisation is claimed.
Verify the exact precursor route and product type, current Review Programme status and deadlines, the applicable GB Article 95 supply chain, product label and other national requirements. Article 95 listing is a supply-chain requirement, not product authorisation, an efficacy assessment or an HSE endorsement.
Key Data & Statistics
Product-specific
Any EN reduction claim must state organism, matrix, concentration, contact time and conditions
Site-specific
Residual persistence must be demonstrated under actual operating conditions
Verify
Biofilm and efficacy outcomes require product-specific evidence
PT2/4/5/11
Stated product types supplied under applicable GB transitional arrangements
How to Deploy Regenerative ClO2 in a Water System
A practical sequence for moving an existing water hygiene programme onto ChloroKlean Plus L20 regenerative chlorine dioxide.
Confirm Product Type and Lawful Route
Match the intended use to the relevant product type and verify Plus L20's applicable GB transitional route, including precursor-route and PT Review Programme status, Article 95 supply chain and current deadline. Pull the SDS, TDS and label.
Baseline the System
Before switching chemistry, record current Legionella counts, TVC, biofilm indicators, chlorine residuals, pH, temperature, and any persistent hot spots or dead legs. This baseline is what you will measure improvement against.
Set the Target Residual and Dose Rate
Use the current product conditions and a competent site assessment to set any free ClO2 residual and dose rate. Do not infer a target from third-party studies or another application.
Install Dosing and Monitoring
Install or repurpose dosing equipment suitable for the product. Confirm the sampling regime: ClO2 residual at distal points, microbiology in line with the written scheme of treatment, and routine review of trend data.
Transition and Monitor
Begin only under the permitted product conditions and site plan. Use the plan's representative residual and microbiological schedule, and change dosing only through competent review of the complete evidence.
Expert Insights
About the Reviewer
Gavin Owen
Managing Director, ChloroKlean
Gavin Owen leads ChloroKlean's technical and commercial operations, bringing over 20 years of experience in industrial chemical distribution and water treatment. He oversees product development, regulatory compliance strategy, and the company's BPR compliance programme across PT2, PT4, PT5, and PT11 product types. Gavin works directly with water treatment professionals, facilities managers, and public health engineers across healthcare, leisure, food processing, and industrial sectors.
Related Products
BPR-compliant chlorine dioxide products available from ChloroKlean.
Frequently Asked Questions
Common questions about this topic, answered by our technical team.
Important Safety Information
- ChloroKlean Plus L20 in concentrate is a hazardous oxidiser. Use PPE in line with the Safety Data Sheet.
- Do not mix the concentrate with acids, reducing agents, or other biocides outside the documented dosing programme.
- Maintain ClO2 residual monitoring at distal points and review trend data against the written scheme of treatment.
- For potable water systems, chlorine dioxide, chlorite and chlorate must remain within the applicable DWI conditions (combined ≤ 0.5 mg/L as chlorine dioxide in water entering public supply) and WHO provisional guideline values for chlorite and chlorate (0.7 mg/L each).
- Operators of systems within scope of ACOP L8 must maintain a written scheme of treatment, risk assessment, and competent person oversight.
This page is technical guidance and does not replace the Safety Data Sheet, COSHH assessment, or applicable regulatory requirements. Always refer to the current SDS and consult a competent water treatment specialist where required. ChloroKlean products rely on applicable GB BPR transitional arrangements for stated Great Britain uses; Article 95 is not product authorisation, and no EU or Northern Ireland authorisation is claimed.
Related Resources
Continue exploring our knowledge base and product information.
ChloroKlean Plus L20 Dosing Guide
How product-specific dose and contact-time decisions should be obtained and verified.
Chlorine Dioxide vs Chlorine for Cooling Towers
Side-by-side comparison of ClO2 and sodium hypochlorite in HSG274-scope systems.
Legionella Control ACOP L8 Guide
How claimed regenerative ClO2 should be assessed within an ACOP L8 written scheme.
Technology Overview
The science behind ChloroKlean's regenerative chlorine dioxide technology.
Hospital Legionella Case Study
Marketing summaries depict later non-detection in hospital water; original sampling records are unavailable, and elimination or treatment causation is not established.
Biofilm Management
How biofilm evidence, cleaning and verification fit together.
Sources & References
This article references guidance from the following authoritative sources:
- Virucidal activity of chlorine dioxide in combination with acetic acid or citric acid and a surfactant, in presence of interfering substances (12 August 2024)
Industry Standard - GMS Hygiene and Infection Control 19: Doc37
- Biocidal Products Regulation (BPR, Regulation (EU) 528/2012)
ECHA - European Chemicals Agency
- ACOP L8: Legionnaires' disease - Control of legionella bacteria in water systems
HSE - Health and Safety Executive
- HSG274 Part 1: The control of legionella bacteria in evaporative cooling systems
HSE - Health and Safety Executive
- Guidelines for Drinking-water Quality - Chlorine Dioxide
WHO - World Health Organization
- GB Review Programme for existing biocidal active substances
HSE - Health and Safety Executive
- GB Article 95: the basics
HSE - Health and Safety Executive
External links open in a new window. ChloroKlean is not responsible for the content of external websites.